nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—ABCC10—Methotrexate—multiple sclerosis	0.101	0.16	CbGbCtD
Sildenafil—CYP2E1—Fingolimod—multiple sclerosis	0.0946	0.15	CbGbCtD
Sildenafil—ABCC4—Methotrexate—multiple sclerosis	0.0483	0.0768	CbGbCtD
Sildenafil—CYP2D6—Fingolimod—multiple sclerosis	0.0451	0.0717	CbGbCtD
Sildenafil—CYP2E1—Mitoxantrone—multiple sclerosis	0.0445	0.0707	CbGbCtD
Sildenafil—CYP1A1—Dexamethasone—multiple sclerosis	0.0298	0.0475	CbGbCtD
Sildenafil—CYP3A4—Fingolimod—multiple sclerosis	0.0287	0.0456	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0239	0.038	CbGbCtD
Sildenafil—CYP3A7—Dexamethasone—multiple sclerosis	0.0239	0.038	CbGbCtD
Sildenafil—CYP2C19—Prednisone—multiple sclerosis	0.0231	0.0368	CbGbCtD
Sildenafil—CYP2E1—Dexamethasone—multiple sclerosis	0.0231	0.0367	CbGbCtD
Sildenafil—CYP3A4—Methylprednisolone—multiple sclerosis	0.0185	0.0294	CbGbCtD
Sildenafil—CYP3A5—Dexamethasone—multiple sclerosis	0.0179	0.0285	CbGbCtD
Sildenafil—PDE6H—pineal body—multiple sclerosis	0.0154	0.233	CbGeAlD
Sildenafil—CYP2C19—Dexamethasone—multiple sclerosis	0.0145	0.023	CbGbCtD
Sildenafil—CYP3A4—Triamcinolone—multiple sclerosis	0.014	0.0223	CbGbCtD
Sildenafil—CYP3A4—Mitoxantrone—multiple sclerosis	0.0135	0.0214	CbGbCtD
Sildenafil—CYP2C9—Dexamethasone—multiple sclerosis	0.012	0.0191	CbGbCtD
Sildenafil—CYP3A4—Betamethasone—multiple sclerosis	0.012	0.0191	CbGbCtD
Sildenafil—CYP3A4—Prednisolone—multiple sclerosis	0.0118	0.0188	CbGbCtD
Sildenafil—CYP3A4—Prednisone—multiple sclerosis	0.0112	0.0178	CbGbCtD
Sildenafil—CYP2D6—Dexamethasone—multiple sclerosis	0.011	0.0175	CbGbCtD
Sildenafil—PDE6C—retina—multiple sclerosis	0.00785	0.119	CbGeAlD
Sildenafil—CYP3A4—Dexamethasone—multiple sclerosis	0.00699	0.0111	CbGbCtD
Sildenafil—PDE6H—retina—multiple sclerosis	0.00463	0.07	CbGeAlD
Sildenafil—PDE6G—retina—multiple sclerosis	0.00445	0.0674	CbGeAlD
Sildenafil—PDE6H—nervous system—multiple sclerosis	0.00251	0.038	CbGeAlD
Sildenafil—PDE6H—central nervous system—multiple sclerosis	0.00242	0.0366	CbGeAlD
Sildenafil—PDE6H—brain—multiple sclerosis	0.00192	0.0291	CbGeAlD
Sildenafil—PDE5A—retina—multiple sclerosis	0.00176	0.0266	CbGeAlD
Sildenafil—ABCC5—retina—multiple sclerosis	0.00161	0.0244	CbGeAlD
Sildenafil—ADORA2A—spinal cord—multiple sclerosis	0.00125	0.0188	CbGeAlD
Sildenafil—ABCC5—medulla oblongata—multiple sclerosis	0.00116	0.0176	CbGeAlD
Sildenafil—ABCC5—midbrain—multiple sclerosis	0.00106	0.0161	CbGeAlD
Sildenafil—ADORA2A—nervous system—multiple sclerosis	0.00105	0.0159	CbGeAlD
Sildenafil—ADORA2A—central nervous system—multiple sclerosis	0.00101	0.0153	CbGeAlD
Sildenafil—ADORA2A—cerebellum—multiple sclerosis	0.000987	0.0149	CbGeAlD
Sildenafil—ABCC10—medulla oblongata—multiple sclerosis	0.000972	0.0147	CbGeAlD
Sildenafil—PDE5A—nervous system—multiple sclerosis	0.000956	0.0145	CbGeAlD
Sildenafil—PDE5A—central nervous system—multiple sclerosis	0.00092	0.0139	CbGeAlD
Sildenafil—PDE5A—cerebellum—multiple sclerosis	0.000899	0.0136	CbGeAlD
Sildenafil—ABCC10—midbrain—multiple sclerosis	0.000888	0.0134	CbGeAlD
Sildenafil—ABCC10—spinal cord—multiple sclerosis	0.000867	0.0131	CbGeAlD
Sildenafil—ABCC5—cerebellum—multiple sclerosis	0.000823	0.0124	CbGeAlD
Sildenafil—ADORA2A—brain—multiple sclerosis	0.000802	0.0121	CbGeAlD
Sildenafil—PDE5A—brain—multiple sclerosis	0.000731	0.0111	CbGeAlD
Sildenafil—ABCC10—cerebellum—multiple sclerosis	0.000687	0.0104	CbGeAlD
Sildenafil—ABCC5—brain—multiple sclerosis	0.000668	0.0101	CbGeAlD
Sildenafil—ABCC4—nervous system—multiple sclerosis	0.000606	0.00917	CbGeAlD
Sildenafil—ABCC4—central nervous system—multiple sclerosis	0.000583	0.00883	CbGeAlD
Sildenafil—CYP2D6—brainstem—multiple sclerosis	0.00056	0.00847	CbGeAlD
Sildenafil—ABCC10—brain—multiple sclerosis	0.000558	0.00845	CbGeAlD
Sildenafil—CYP2E1—medulla oblongata—multiple sclerosis	0.000493	0.00746	CbGeAlD
Sildenafil—ABCC4—brain—multiple sclerosis	0.000463	0.00701	CbGeAlD
Sildenafil—CYP2E1—spinal cord—multiple sclerosis	0.000439	0.00665	CbGeAlD
Sildenafil—CYP1A1—nervous system—multiple sclerosis	0.000406	0.00615	CbGeAlD
Sildenafil—CYP1A1—central nervous system—multiple sclerosis	0.000391	0.00592	CbGeAlD
Sildenafil—CYP2E1—nervous system—multiple sclerosis	0.00037	0.0056	CbGeAlD
Sildenafil—CYP2E1—central nervous system—multiple sclerosis	0.000356	0.0054	CbGeAlD
Sildenafil—CYP2E1—cerebellum—multiple sclerosis	0.000348	0.00527	CbGeAlD
Sildenafil—CYP1A1—brain—multiple sclerosis	0.00031	0.0047	CbGeAlD
Sildenafil—CYP3A4—nervous system—multiple sclerosis	0.000298	0.00451	CbGeAlD
Sildenafil—CYP2D6—nervous system—multiple sclerosis	0.000293	0.00444	CbGeAlD
Sildenafil—CYP3A4—central nervous system—multiple sclerosis	0.000287	0.00434	CbGeAlD
Sildenafil—CYP2E1—brain—multiple sclerosis	0.000283	0.00428	CbGeAlD
Sildenafil—CYP2D6—central nervous system—multiple sclerosis	0.000282	0.00427	CbGeAlD
Sildenafil—CYP2D6—cerebellum—multiple sclerosis	0.000276	0.00418	CbGeAlD
Sildenafil—CYP2D6—brain—multiple sclerosis	0.000224	0.00339	CbGeAlD
Sildenafil—Alopecia—Prednisone—multiple sclerosis	0.000138	0.000557	CcSEcCtD
Sildenafil—Shock—Methylprednisolone—multiple sclerosis	0.000138	0.000556	CcSEcCtD
Sildenafil—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000138	0.000555	CcSEcCtD
Sildenafil—Loss of consciousness—Betamethasone—multiple sclerosis	0.000138	0.000554	CcSEcCtD
Sildenafil—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000138	0.000554	CcSEcCtD
Sildenafil—Epistaxis—Methotrexate—multiple sclerosis	0.000138	0.000553	CcSEcCtD
Sildenafil—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000138	0.000553	CcSEcCtD
Sildenafil—Paraesthesia—Prednisolone—multiple sclerosis	0.000138	0.000553	CcSEcCtD
Sildenafil—Tachycardia—Triamcinolone—multiple sclerosis	0.000138	0.000553	CcSEcCtD
Sildenafil—Mental disorder—Prednisone—multiple sclerosis	0.000137	0.000552	CcSEcCtD
Sildenafil—Nausea—Azathioprine—multiple sclerosis	0.000137	0.000552	CcSEcCtD
Sildenafil—Tachycardia—Methylprednisolone—multiple sclerosis	0.000137	0.000552	CcSEcCtD
Sildenafil—Skin disorder—Methylprednisolone—multiple sclerosis	0.000137	0.000549	CcSEcCtD
Sildenafil—Erythema—Prednisone—multiple sclerosis	0.000136	0.000549	CcSEcCtD
Sildenafil—Malnutrition—Prednisone—multiple sclerosis	0.000136	0.000549	CcSEcCtD
Sildenafil—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000136	0.000548	CcSEcCtD
Sildenafil—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000136	0.000547	CcSEcCtD
Sildenafil—Convulsion—Dexamethasone—multiple sclerosis	0.000136	0.000546	CcSEcCtD
Sildenafil—Convulsion—Betamethasone—multiple sclerosis	0.000136	0.000546	CcSEcCtD
Sildenafil—Hypertension—Betamethasone—multiple sclerosis	0.000135	0.000544	CcSEcCtD
Sildenafil—Hypertension—Dexamethasone—multiple sclerosis	0.000135	0.000544	CcSEcCtD
Sildenafil—Asthenia—Mitoxantrone—multiple sclerosis	0.000134	0.000539	CcSEcCtD
Sildenafil—Myalgia—Dexamethasone—multiple sclerosis	0.000133	0.000536	CcSEcCtD
Sildenafil—Myalgia—Betamethasone—multiple sclerosis	0.000133	0.000536	CcSEcCtD
Sildenafil—Anxiety—Betamethasone—multiple sclerosis	0.000133	0.000535	CcSEcCtD
Sildenafil—Anxiety—Dexamethasone—multiple sclerosis	0.000133	0.000535	CcSEcCtD
Sildenafil—Discomfort—Betamethasone—multiple sclerosis	0.000132	0.00053	CcSEcCtD
Sildenafil—Discomfort—Dexamethasone—multiple sclerosis	0.000132	0.00053	CcSEcCtD
Sildenafil—Haemoglobin—Methotrexate—multiple sclerosis	0.000132	0.000529	CcSEcCtD
Sildenafil—Hypotension—Methylprednisolone—multiple sclerosis	0.000131	0.000528	CcSEcCtD
Sildenafil—Pain—Prednisolone—multiple sclerosis	0.000131	0.000527	CcSEcCtD
Sildenafil—Haemorrhage—Methotrexate—multiple sclerosis	0.000131	0.000527	CcSEcCtD
Sildenafil—Pharyngitis—Methotrexate—multiple sclerosis	0.00013	0.000523	CcSEcCtD
Sildenafil—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000129	0.00052	CcSEcCtD
Sildenafil—Vision blurred—Prednisone—multiple sclerosis	0.000129	0.000517	CcSEcCtD
Sildenafil—Urethral disorder—Methotrexate—multiple sclerosis	0.000128	0.000516	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000128	0.000516	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000128	0.000515	CcSEcCtD
Sildenafil—Oedema—Betamethasone—multiple sclerosis	0.000128	0.000514	CcSEcCtD
Sildenafil—Oedema—Dexamethasone—multiple sclerosis	0.000128	0.000514	CcSEcCtD
Sildenafil—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000128	0.000514	CcSEcCtD
Sildenafil—Insomnia—Triamcinolone—multiple sclerosis	0.000127	0.000513	CcSEcCtD
Sildenafil—Insomnia—Methylprednisolone—multiple sclerosis	0.000127	0.000511	CcSEcCtD
Sildenafil—Infection—Betamethasone—multiple sclerosis	0.000127	0.000511	CcSEcCtD
Sildenafil—Infection—Dexamethasone—multiple sclerosis	0.000127	0.000511	CcSEcCtD
Sildenafil—Ill-defined disorder—Prednisone—multiple sclerosis	0.000127	0.000509	CcSEcCtD
Sildenafil—Paraesthesia—Triamcinolone—multiple sclerosis	0.000127	0.000509	CcSEcCtD
Sildenafil—Feeling abnormal—Prednisolone—multiple sclerosis	0.000126	0.000508	CcSEcCtD
Sildenafil—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000126	0.000508	CcSEcCtD
Sildenafil—Visual impairment—Methotrexate—multiple sclerosis	0.000126	0.000508	CcSEcCtD
Sildenafil—Anaemia—Prednisone—multiple sclerosis	0.000126	0.000507	CcSEcCtD
Sildenafil—Shock—Dexamethasone—multiple sclerosis	0.000126	0.000506	CcSEcCtD
Sildenafil—Shock—Betamethasone—multiple sclerosis	0.000126	0.000506	CcSEcCtD
Sildenafil—Dyspnoea—Triamcinolone—multiple sclerosis	0.000126	0.000505	CcSEcCtD
Sildenafil—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000125	0.000504	CcSEcCtD
Sildenafil—Nervous system disorder—Betamethasone—multiple sclerosis	0.000125	0.000504	CcSEcCtD
Sildenafil—Agitation—Prednisone—multiple sclerosis	0.000125	0.000504	CcSEcCtD
Sildenafil—Tachycardia—Dexamethasone—multiple sclerosis	0.000125	0.000502	CcSEcCtD
Sildenafil—Tachycardia—Betamethasone—multiple sclerosis	0.000125	0.000502	CcSEcCtD
Sildenafil—Dyspepsia—Triamcinolone—multiple sclerosis	0.000124	0.000499	CcSEcCtD
Sildenafil—Erythema multiforme—Methotrexate—multiple sclerosis	0.000124	0.000498	CcSEcCtD
Sildenafil—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000124	0.000498	CcSEcCtD
Sildenafil—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000124	0.000497	CcSEcCtD
Sildenafil—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000124	0.000497	CcSEcCtD
Sildenafil—Malaise—Prednisone—multiple sclerosis	0.000123	0.000495	CcSEcCtD
Sildenafil—Vertigo—Prednisone—multiple sclerosis	0.000123	0.000493	CcSEcCtD
Sildenafil—Eye disorder—Methotrexate—multiple sclerosis	0.000122	0.000492	CcSEcCtD
Sildenafil—Syncope—Prednisone—multiple sclerosis	0.000122	0.000492	CcSEcCtD
Sildenafil—Tinnitus—Methotrexate—multiple sclerosis	0.000122	0.000491	CcSEcCtD
Sildenafil—Anorexia—Betamethasone—multiple sclerosis	0.000122	0.00049	CcSEcCtD
Sildenafil—Anorexia—Dexamethasone—multiple sclerosis	0.000122	0.00049	CcSEcCtD
Sildenafil—Urticaria—Prednisolone—multiple sclerosis	0.000122	0.00049	CcSEcCtD
Sildenafil—Cardiac disorder—Methotrexate—multiple sclerosis	0.000122	0.000489	CcSEcCtD
Sildenafil—Fatigue—Triamcinolone—multiple sclerosis	0.000121	0.000489	CcSEcCtD
Sildenafil—Fatigue—Methylprednisolone—multiple sclerosis	0.000121	0.000488	CcSEcCtD
Sildenafil—Pain—Triamcinolone—multiple sclerosis	0.00012	0.000485	CcSEcCtD
Sildenafil—Loss of consciousness—Prednisone—multiple sclerosis	0.00012	0.000482	CcSEcCtD
Sildenafil—Hypotension—Dexamethasone—multiple sclerosis	0.000119	0.00048	CcSEcCtD
Sildenafil—Hypotension—Betamethasone—multiple sclerosis	0.000119	0.00048	CcSEcCtD
Sildenafil—Angiopathy—Methotrexate—multiple sclerosis	0.000119	0.000478	CcSEcCtD
Sildenafil—Vomiting—Mitoxantrone—multiple sclerosis	0.000119	0.000478	CcSEcCtD
Sildenafil—Immune system disorder—Methotrexate—multiple sclerosis	0.000118	0.000476	CcSEcCtD
Sildenafil—Convulsion—Prednisone—multiple sclerosis	0.000118	0.000475	CcSEcCtD
Sildenafil—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000118	0.000475	CcSEcCtD
Sildenafil—Hypertension—Prednisone—multiple sclerosis	0.000118	0.000474	CcSEcCtD
Sildenafil—Rash—Mitoxantrone—multiple sclerosis	0.000118	0.000474	CcSEcCtD
Sildenafil—Dermatitis—Mitoxantrone—multiple sclerosis	0.000118	0.000473	CcSEcCtD
Sildenafil—Chills—Methotrexate—multiple sclerosis	0.000118	0.000473	CcSEcCtD
Sildenafil—Headache—Mitoxantrone—multiple sclerosis	0.000117	0.000471	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000116	0.000468	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000116	0.000468	CcSEcCtD
Sildenafil—Arthralgia—Prednisone—multiple sclerosis	0.000116	0.000467	CcSEcCtD
Sildenafil—Myalgia—Prednisone—multiple sclerosis	0.000116	0.000467	CcSEcCtD
Sildenafil—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000116	0.000467	CcSEcCtD
Sildenafil—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000116	0.000466	CcSEcCtD
Sildenafil—Anxiety—Prednisone—multiple sclerosis	0.000116	0.000466	CcSEcCtD
Sildenafil—Alopecia—Methotrexate—multiple sclerosis	0.000116	0.000465	CcSEcCtD
Sildenafil—Insomnia—Dexamethasone—multiple sclerosis	0.000116	0.000465	CcSEcCtD
Sildenafil—Insomnia—Betamethasone—multiple sclerosis	0.000116	0.000465	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000115	0.000464	CcSEcCtD
Sildenafil—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000115	0.000462	CcSEcCtD
Sildenafil—Paraesthesia—Betamethasone—multiple sclerosis	0.000115	0.000462	CcSEcCtD
Sildenafil—Paraesthesia—Dexamethasone—multiple sclerosis	0.000115	0.000462	CcSEcCtD
Sildenafil—Discomfort—Prednisone—multiple sclerosis	0.000115	0.000462	CcSEcCtD
Sildenafil—Mental disorder—Methotrexate—multiple sclerosis	0.000115	0.000461	CcSEcCtD
Sildenafil—Erythema—Methotrexate—multiple sclerosis	0.000114	0.000459	CcSEcCtD
Sildenafil—Malnutrition—Methotrexate—multiple sclerosis	0.000114	0.000459	CcSEcCtD
Sildenafil—Hypersensitivity—Prednisolone—multiple sclerosis	0.000113	0.000454	CcSEcCtD
Sildenafil—Dyspepsia—Dexamethasone—multiple sclerosis	0.000113	0.000453	CcSEcCtD
Sildenafil—Dyspepsia—Betamethasone—multiple sclerosis	0.000113	0.000453	CcSEcCtD
Sildenafil—Urticaria—Triamcinolone—multiple sclerosis	0.000112	0.00045	CcSEcCtD
Sildenafil—Urticaria—Methylprednisolone—multiple sclerosis	0.000112	0.000449	CcSEcCtD
Sildenafil—Body temperature increased—Triamcinolone—multiple sclerosis	0.000111	0.000448	CcSEcCtD
Sildenafil—Oedema—Prednisone—multiple sclerosis	0.000111	0.000448	CcSEcCtD
Sildenafil—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000111	0.000447	CcSEcCtD
Sildenafil—Decreased appetite—Betamethasone—multiple sclerosis	0.000111	0.000447	CcSEcCtD
Sildenafil—Decreased appetite—Dexamethasone—multiple sclerosis	0.000111	0.000447	CcSEcCtD
Sildenafil—Nausea—Mitoxantrone—multiple sclerosis	0.000111	0.000446	CcSEcCtD
Sildenafil—Infection—Prednisone—multiple sclerosis	0.000111	0.000445	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00011	0.000444	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00011	0.000444	CcSEcCtD
Sildenafil—Back pain—Methotrexate—multiple sclerosis	0.00011	0.000444	CcSEcCtD
Sildenafil—Fatigue—Betamethasone—multiple sclerosis	0.00011	0.000443	CcSEcCtD
Sildenafil—Fatigue—Dexamethasone—multiple sclerosis	0.00011	0.000443	CcSEcCtD
Sildenafil—Shock—Prednisone—multiple sclerosis	0.00011	0.000441	CcSEcCtD
Sildenafil—Pain—Dexamethasone—multiple sclerosis	0.000109	0.00044	CcSEcCtD
Sildenafil—Pain—Betamethasone—multiple sclerosis	0.000109	0.00044	CcSEcCtD
Sildenafil—Nervous system disorder—Prednisone—multiple sclerosis	0.000109	0.000439	CcSEcCtD
Sildenafil—Tachycardia—Prednisone—multiple sclerosis	0.000109	0.000437	CcSEcCtD
Sildenafil—Skin disorder—Prednisone—multiple sclerosis	0.000108	0.000435	CcSEcCtD
Sildenafil—Hyperhidrosis—Prednisone—multiple sclerosis	0.000108	0.000433	CcSEcCtD
Sildenafil—Vision blurred—Methotrexate—multiple sclerosis	0.000107	0.000432	CcSEcCtD
Sildenafil—Anorexia—Prednisone—multiple sclerosis	0.000106	0.000427	CcSEcCtD
Sildenafil—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000106	0.000425	CcSEcCtD
Sildenafil—Anaemia—Methotrexate—multiple sclerosis	0.000105	0.000424	CcSEcCtD
Sildenafil—Feeling abnormal—Betamethasone—multiple sclerosis	0.000105	0.000424	CcSEcCtD
Sildenafil—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000105	0.000424	CcSEcCtD
Sildenafil—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000105	0.00042	CcSEcCtD
Sildenafil—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000105	0.00042	CcSEcCtD
Sildenafil—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000104	0.000418	CcSEcCtD
Sildenafil—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000104	0.000417	CcSEcCtD
Sildenafil—Malaise—Methotrexate—multiple sclerosis	0.000103	0.000414	CcSEcCtD
Sildenafil—Vertigo—Methotrexate—multiple sclerosis	0.000102	0.000412	CcSEcCtD
Sildenafil—Leukopenia—Methotrexate—multiple sclerosis	0.000102	0.00041	CcSEcCtD
Sildenafil—Urticaria—Betamethasone—multiple sclerosis	0.000102	0.000408	CcSEcCtD
Sildenafil—Urticaria—Dexamethasone—multiple sclerosis	0.000102	0.000408	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000101	0.000408	CcSEcCtD
Sildenafil—Dizziness—Prednisolone—multiple sclerosis	0.000101	0.000408	CcSEcCtD
Sildenafil—Asthenia—Triamcinolone—multiple sclerosis	0.000101	0.000407	CcSEcCtD
Sildenafil—Abdominal pain—Betamethasone—multiple sclerosis	0.000101	0.000406	CcSEcCtD
Sildenafil—Abdominal pain—Dexamethasone—multiple sclerosis	0.000101	0.000406	CcSEcCtD
Sildenafil—Body temperature increased—Betamethasone—multiple sclerosis	0.000101	0.000406	CcSEcCtD
Sildenafil—Body temperature increased—Dexamethasone—multiple sclerosis	0.000101	0.000406	CcSEcCtD
Sildenafil—Asthenia—Methylprednisolone—multiple sclerosis	0.000101	0.000406	CcSEcCtD
Sildenafil—Insomnia—Prednisone—multiple sclerosis	0.000101	0.000405	CcSEcCtD
Sildenafil—Paraesthesia—Prednisone—multiple sclerosis	0.0001	0.000402	CcSEcCtD
Sildenafil—Pruritus—Triamcinolone—multiple sclerosis	9.97e-05	0.000401	CcSEcCtD
Sildenafil—Cough—Methotrexate—multiple sclerosis	9.95e-05	0.0004	CcSEcCtD
Sildenafil—Pruritus—Methylprednisolone—multiple sclerosis	9.95e-05	0.0004	CcSEcCtD
Sildenafil—Convulsion—Methotrexate—multiple sclerosis	9.88e-05	0.000397	CcSEcCtD
Sildenafil—Dyspepsia—Prednisone—multiple sclerosis	9.8e-05	0.000394	CcSEcCtD
Sildenafil—Myalgia—Methotrexate—multiple sclerosis	9.71e-05	0.00039	CcSEcCtD
Sildenafil—Chest pain—Methotrexate—multiple sclerosis	9.71e-05	0.00039	CcSEcCtD
Sildenafil—Arthralgia—Methotrexate—multiple sclerosis	9.71e-05	0.00039	CcSEcCtD
Sildenafil—Decreased appetite—Prednisone—multiple sclerosis	9.68e-05	0.000389	CcSEcCtD
Sildenafil—Rash—Prednisolone—multiple sclerosis	9.66e-05	0.000389	CcSEcCtD
Sildenafil—Dermatitis—Prednisolone—multiple sclerosis	9.65e-05	0.000388	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	9.64e-05	0.000388	CcSEcCtD
Sildenafil—Diarrhoea—Methylprednisolone—multiple sclerosis	9.62e-05	0.000387	CcSEcCtD
Sildenafil—Fatigue—Prednisone—multiple sclerosis	9.6e-05	0.000386	CcSEcCtD
Sildenafil—Headache—Prednisolone—multiple sclerosis	9.6e-05	0.000386	CcSEcCtD
Sildenafil—Discomfort—Methotrexate—multiple sclerosis	9.59e-05	0.000386	CcSEcCtD
Sildenafil—Constipation—Prednisone—multiple sclerosis	9.52e-05	0.000383	CcSEcCtD
Sildenafil—Dizziness—Triamcinolone—multiple sclerosis	9.32e-05	0.000375	CcSEcCtD
Sildenafil—Dizziness—Methylprednisolone—multiple sclerosis	9.3e-05	0.000374	CcSEcCtD
Sildenafil—Infection—Methotrexate—multiple sclerosis	9.24e-05	0.000372	CcSEcCtD
Sildenafil—Feeling abnormal—Prednisone—multiple sclerosis	9.17e-05	0.000369	CcSEcCtD
Sildenafil—Asthenia—Betamethasone—multiple sclerosis	9.17e-05	0.000369	CcSEcCtD
Sildenafil—Asthenia—Dexamethasone—multiple sclerosis	9.17e-05	0.000369	CcSEcCtD
Sildenafil—Nervous system disorder—Methotrexate—multiple sclerosis	9.12e-05	0.000367	CcSEcCtD
Sildenafil—Gastrointestinal pain—Prednisone—multiple sclerosis	9.1e-05	0.000366	CcSEcCtD
Sildenafil—Nausea—Prednisolone—multiple sclerosis	9.1e-05	0.000366	CcSEcCtD
Sildenafil—Pruritus—Dexamethasone—multiple sclerosis	9.04e-05	0.000364	CcSEcCtD
Sildenafil—Pruritus—Betamethasone—multiple sclerosis	9.04e-05	0.000364	CcSEcCtD
Sildenafil—Skin disorder—Methotrexate—multiple sclerosis	9.04e-05	0.000364	CcSEcCtD
Sildenafil—Hyperhidrosis—Methotrexate—multiple sclerosis	8.99e-05	0.000362	CcSEcCtD
Sildenafil—Vomiting—Triamcinolone—multiple sclerosis	8.96e-05	0.00036	CcSEcCtD
Sildenafil—Vomiting—Methylprednisolone—multiple sclerosis	8.94e-05	0.00036	CcSEcCtD
Sildenafil—Rash—Triamcinolone—multiple sclerosis	8.88e-05	0.000357	CcSEcCtD
Sildenafil—Dermatitis—Triamcinolone—multiple sclerosis	8.87e-05	0.000357	CcSEcCtD
Sildenafil—Anorexia—Methotrexate—multiple sclerosis	8.87e-05	0.000357	CcSEcCtD
Sildenafil—Rash—Methylprednisolone—multiple sclerosis	8.86e-05	0.000357	CcSEcCtD
Sildenafil—Dermatitis—Methylprednisolone—multiple sclerosis	8.86e-05	0.000356	CcSEcCtD
Sildenafil—Urticaria—Prednisone—multiple sclerosis	8.84e-05	0.000356	CcSEcCtD
Sildenafil—Headache—Triamcinolone—multiple sclerosis	8.83e-05	0.000355	CcSEcCtD
Sildenafil—Headache—Methylprednisolone—multiple sclerosis	8.81e-05	0.000354	CcSEcCtD
Sildenafil—Abdominal pain—Prednisone—multiple sclerosis	8.8e-05	0.000354	CcSEcCtD
Sildenafil—Body temperature increased—Prednisone—multiple sclerosis	8.8e-05	0.000354	CcSEcCtD
Sildenafil—Diarrhoea—Betamethasone—multiple sclerosis	8.75e-05	0.000352	CcSEcCtD
Sildenafil—Diarrhoea—Dexamethasone—multiple sclerosis	8.75e-05	0.000352	CcSEcCtD
Sildenafil—Hypotension—Methotrexate—multiple sclerosis	8.69e-05	0.00035	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	8.48e-05	0.000341	CcSEcCtD
Sildenafil—Dizziness—Betamethasone—multiple sclerosis	8.45e-05	0.00034	CcSEcCtD
Sildenafil—Dizziness—Dexamethasone—multiple sclerosis	8.45e-05	0.00034	CcSEcCtD
Sildenafil—Insomnia—Methotrexate—multiple sclerosis	8.41e-05	0.000338	CcSEcCtD
Sildenafil—Nausea—Triamcinolone—multiple sclerosis	8.37e-05	0.000337	CcSEcCtD
Sildenafil—Paraesthesia—Methotrexate—multiple sclerosis	8.35e-05	0.000336	CcSEcCtD
Sildenafil—Nausea—Methylprednisolone—multiple sclerosis	8.35e-05	0.000336	CcSEcCtD
Sildenafil—Dyspnoea—Methotrexate—multiple sclerosis	8.29e-05	0.000334	CcSEcCtD
Sildenafil—Somnolence—Methotrexate—multiple sclerosis	8.27e-05	0.000333	CcSEcCtD
Sildenafil—Hypersensitivity—Prednisone—multiple sclerosis	8.2e-05	0.00033	CcSEcCtD
Sildenafil—Dyspepsia—Methotrexate—multiple sclerosis	8.19e-05	0.000329	CcSEcCtD
Sildenafil—Vomiting—Betamethasone—multiple sclerosis	8.13e-05	0.000327	CcSEcCtD
Sildenafil—Vomiting—Dexamethasone—multiple sclerosis	8.13e-05	0.000327	CcSEcCtD
Sildenafil—Decreased appetite—Methotrexate—multiple sclerosis	8.09e-05	0.000325	CcSEcCtD
Sildenafil—Rash—Betamethasone—multiple sclerosis	8.06e-05	0.000324	CcSEcCtD
Sildenafil—Rash—Dexamethasone—multiple sclerosis	8.06e-05	0.000324	CcSEcCtD
Sildenafil—Dermatitis—Dexamethasone—multiple sclerosis	8.05e-05	0.000324	CcSEcCtD
Sildenafil—Dermatitis—Betamethasone—multiple sclerosis	8.05e-05	0.000324	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Methotrexate—multiple sclerosis	8.03e-05	0.000323	CcSEcCtD
Sildenafil—Fatigue—Methotrexate—multiple sclerosis	8.02e-05	0.000323	CcSEcCtD
Sildenafil—Headache—Dexamethasone—multiple sclerosis	8.01e-05	0.000322	CcSEcCtD
Sildenafil—Headache—Betamethasone—multiple sclerosis	8.01e-05	0.000322	CcSEcCtD
Sildenafil—Asthenia—Prednisone—multiple sclerosis	7.99e-05	0.000321	CcSEcCtD
Sildenafil—Pain—Methotrexate—multiple sclerosis	7.96e-05	0.00032	CcSEcCtD
Sildenafil—Pruritus—Prednisone—multiple sclerosis	7.88e-05	0.000317	CcSEcCtD
Sildenafil—Feeling abnormal—Methotrexate—multiple sclerosis	7.67e-05	0.000308	CcSEcCtD
Sildenafil—Diarrhoea—Prednisone—multiple sclerosis	7.62e-05	0.000306	CcSEcCtD
Sildenafil—Gastrointestinal pain—Methotrexate—multiple sclerosis	7.61e-05	0.000306	CcSEcCtD
Sildenafil—Nausea—Dexamethasone—multiple sclerosis	7.59e-05	0.000305	CcSEcCtD
Sildenafil—Nausea—Betamethasone—multiple sclerosis	7.59e-05	0.000305	CcSEcCtD
Sildenafil—Urticaria—Methotrexate—multiple sclerosis	7.39e-05	0.000297	CcSEcCtD
Sildenafil—Dizziness—Prednisone—multiple sclerosis	7.36e-05	0.000296	CcSEcCtD
Sildenafil—Abdominal pain—Methotrexate—multiple sclerosis	7.35e-05	0.000296	CcSEcCtD
Sildenafil—Body temperature increased—Methotrexate—multiple sclerosis	7.35e-05	0.000296	CcSEcCtD
Sildenafil—Vomiting—Prednisone—multiple sclerosis	7.08e-05	0.000285	CcSEcCtD
Sildenafil—Rash—Prednisone—multiple sclerosis	7.02e-05	0.000282	CcSEcCtD
Sildenafil—Dermatitis—Prednisone—multiple sclerosis	7.01e-05	0.000282	CcSEcCtD
Sildenafil—Headache—Prednisone—multiple sclerosis	6.97e-05	0.000281	CcSEcCtD
Sildenafil—Hypersensitivity—Methotrexate—multiple sclerosis	6.85e-05	0.000276	CcSEcCtD
Sildenafil—Asthenia—Methotrexate—multiple sclerosis	6.68e-05	0.000269	CcSEcCtD
Sildenafil—Nausea—Prednisone—multiple sclerosis	6.61e-05	0.000266	CcSEcCtD
Sildenafil—Pruritus—Methotrexate—multiple sclerosis	6.58e-05	0.000265	CcSEcCtD
Sildenafil—Diarrhoea—Methotrexate—multiple sclerosis	6.37e-05	0.000256	CcSEcCtD
Sildenafil—Dizziness—Methotrexate—multiple sclerosis	6.15e-05	0.000247	CcSEcCtD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	6.06e-05	0.00107	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—IL2—multiple sclerosis	5.99e-05	0.00106	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PTGER4—multiple sclerosis	5.95e-05	0.00105	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	5.95e-05	0.00105	CbGpPWpGaD
Sildenafil—Vomiting—Methotrexate—multiple sclerosis	5.92e-05	0.000238	CcSEcCtD
Sildenafil—ADORA2A—Signaling by NGF—CD80—multiple sclerosis	5.89e-05	0.00104	CbGpPWpGaD
Sildenafil—Rash—Methotrexate—multiple sclerosis	5.87e-05	0.000236	CcSEcCtD
Sildenafil—PDE6G—Signaling Pathways—PGR—multiple sclerosis	5.86e-05	0.00104	CbGpPWpGaD
Sildenafil—Dermatitis—Methotrexate—multiple sclerosis	5.86e-05	0.000236	CcSEcCtD
Sildenafil—Headache—Methotrexate—multiple sclerosis	5.83e-05	0.000234	CcSEcCtD
Sildenafil—PDE6G—Disease—CD86—multiple sclerosis	5.8e-05	0.00103	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—SRM—multiple sclerosis	5.78e-05	0.00102	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TAGAP—multiple sclerosis	5.75e-05	0.00102	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CXCR3—multiple sclerosis	5.75e-05	0.00102	CbGpPWpGaD
Sildenafil—ABCC5—Disease—RPL5—multiple sclerosis	5.74e-05	0.00102	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—ITGA4—multiple sclerosis	5.74e-05	0.00102	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—IFNB1—multiple sclerosis	5.7e-05	0.00101	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CD28—multiple sclerosis	5.7e-05	0.00101	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	5.66e-05	0.001	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	5.66e-05	0.001	CbGpPWpGaD
Sildenafil—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.64e-05	0.000998	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—CCL5—multiple sclerosis	5.63e-05	0.000997	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CCR2—multiple sclerosis	5.59e-05	0.00099	CbGpPWpGaD
Sildenafil—Nausea—Methotrexate—multiple sclerosis	5.53e-05	0.000222	CcSEcCtD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	5.5e-05	0.000974	CbGpPWpGaD
Sildenafil—ABCC5—Disease—SLC11A1—multiple sclerosis	5.5e-05	0.000974	CbGpPWpGaD
Sildenafil—CYP3A7—Biological oxidations—POMC—multiple sclerosis	5.36e-05	0.000949	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	5.21e-05	0.000922	CbGpPWpGaD
Sildenafil—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.19e-05	0.000918	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CNR1—multiple sclerosis	5.16e-05	0.000914	CbGpPWpGaD
Sildenafil—PDE6G—Disease—CCR5—multiple sclerosis	5.15e-05	0.000911	CbGpPWpGaD
Sildenafil—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.14e-05	0.00091	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.11e-05	0.000905	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.11e-05	0.000905	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	5.1e-05	0.000902	CbGpPWpGaD
Sildenafil—ABCC4—Ectoderm Differentiation—MYC—multiple sclerosis	5.08e-05	0.0009	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—CCR5—multiple sclerosis	5.08e-05	0.000899	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—S1PR1—multiple sclerosis	5.03e-05	0.00089	CbGpPWpGaD
Sildenafil—PDE6G—Disease—HLA-A—multiple sclerosis	5.02e-05	0.000888	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—TYK2—multiple sclerosis	4.98e-05	0.000881	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—GPC5—multiple sclerosis	4.89e-05	0.000866	CbGpPWpGaD
Sildenafil—ABCC4—NRF2 pathway—TGFB1—multiple sclerosis	4.85e-05	0.000858	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—PTGER4—multiple sclerosis	4.74e-05	0.000839	CbGpPWpGaD
Sildenafil—PDE6G—Disease—APOE—multiple sclerosis	4.68e-05	0.000829	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—TGFB1—multiple sclerosis	4.67e-05	0.000827	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.66e-05	0.000825	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.66e-05	0.000825	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CXCL10—multiple sclerosis	4.65e-05	0.000823	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—MAPK1—multiple sclerosis	4.58e-05	0.000811	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—CXCR3—multiple sclerosis	4.58e-05	0.00081	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—multiple sclerosis	4.53e-05	0.000802	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CCL3—multiple sclerosis	4.47e-05	0.000791	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	4.46e-05	0.00079	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—CCR2—multiple sclerosis	4.45e-05	0.000788	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CD28—multiple sclerosis	4.39e-05	0.000778	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PTGER4—multiple sclerosis	4.3e-05	0.000762	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—RGS1—multiple sclerosis	4.27e-05	0.000757	CbGpPWpGaD
Sildenafil—PDE6G—Disease—CD80—multiple sclerosis	4.23e-05	0.00075	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—SRM—multiple sclerosis	4.19e-05	0.000742	CbGpPWpGaD
Sildenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.18e-05	0.000741	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—SRM—multiple sclerosis	4.18e-05	0.00074	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CXCR3—multiple sclerosis	4.16e-05	0.000736	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAPK1—multiple sclerosis	4.12e-05	0.000729	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—CNR1—multiple sclerosis	4.11e-05	0.000727	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	4.08e-05	0.000721	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	4.08e-05	0.000721	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CD86—multiple sclerosis	4.06e-05	0.00072	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—GPR65—multiple sclerosis	4.05e-05	0.000717	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CCR2—multiple sclerosis	4.04e-05	0.000716	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CCL5—multiple sclerosis	4e-05	0.000708	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—POMC—multiple sclerosis	3.97e-05	0.000702	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SRM—multiple sclerosis	3.95e-05	0.000699	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—IL2RA—multiple sclerosis	3.92e-05	0.000694	CbGpPWpGaD
Sildenafil—CYP2E1—Biological oxidations—POMC—multiple sclerosis	3.88e-05	0.000687	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—CCL2—multiple sclerosis	3.88e-05	0.000687	CbGpPWpGaD
Sildenafil—CYP3A5—Biological oxidations—POMC—multiple sclerosis	3.87e-05	0.000686	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CNR1—multiple sclerosis	3.73e-05	0.00066	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GPC5—multiple sclerosis	3.73e-05	0.00066	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CXCL13—multiple sclerosis	3.71e-05	0.000656	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCR1—multiple sclerosis	3.71e-05	0.000656	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—SPP1—multiple sclerosis	3.71e-05	0.000656	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—CXCL10—multiple sclerosis	3.7e-05	0.000655	CbGpPWpGaD
Sildenafil—CYP1A1—Biological oxidations—POMC—multiple sclerosis	3.66e-05	0.000648	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CCR5—multiple sclerosis	3.61e-05	0.000638	CbGpPWpGaD
Sildenafil—PDE6G—Disease—TYK2—multiple sclerosis	3.57e-05	0.000633	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—IL2RA—multiple sclerosis	3.55e-05	0.000629	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.54e-05	0.000627	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—BCHE—multiple sclerosis	3.52e-05	0.000623	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—STAT3—multiple sclerosis	3.48e-05	0.000617	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	3.48e-05	0.000616	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	3.41e-05	0.000604	CbGpPWpGaD
Sildenafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.39e-05	0.0006	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CXCL10—multiple sclerosis	3.36e-05	0.000595	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—APOE—multiple sclerosis	3.28e-05	0.000581	CbGpPWpGaD
Sildenafil—PDE6G—Disease—CD4—multiple sclerosis	3.23e-05	0.000572	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SRM—multiple sclerosis	3.23e-05	0.000572	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—IL6—multiple sclerosis	3.23e-05	0.000571	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—CCL5—multiple sclerosis	3.18e-05	0.000564	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—MAPK1—multiple sclerosis	3.17e-05	0.000561	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—multiple sclerosis	3.16e-05	0.00056	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CD86—multiple sclerosis	3.13e-05	0.000555	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—RRM1—multiple sclerosis	3.09e-05	0.000547	CbGpPWpGaD
Sildenafil—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3e-05	0.00053	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SRM—multiple sclerosis	2.97e-05	0.000526	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CD80—multiple sclerosis	2.97e-05	0.000525	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	2.95e-05	0.000523	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	2.95e-05	0.000523	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SRM—multiple sclerosis	2.95e-05	0.000522	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	2.95e-05	0.000521	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	2.95e-05	0.000521	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CCL5—multiple sclerosis	2.89e-05	0.000512	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—CCR5—multiple sclerosis	2.87e-05	0.000508	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—ALB—multiple sclerosis	2.84e-05	0.000502	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	2.83e-05	0.0005	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—POMC—multiple sclerosis	2.82e-05	0.000499	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	2.78e-05	0.000493	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	2.78e-05	0.000493	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CCR5—multiple sclerosis	2.78e-05	0.000492	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CCL2—multiple sclerosis	2.76e-05	0.000488	CbGpPWpGaD
Sildenafil—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.76e-05	0.000488	CbGpPWpGaD
Sildenafil—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.73e-05	0.000484	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.72e-05	0.000482	CbGpPWpGaD
Sildenafil—ABCC5—Disease—HLA-A—multiple sclerosis	2.71e-05	0.00048	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GPC5—multiple sclerosis	2.7e-05	0.000478	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GPC5—multiple sclerosis	2.69e-05	0.000477	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCL3—multiple sclerosis	2.64e-05	0.000467	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CCR5—multiple sclerosis	2.6e-05	0.000461	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—IL2RA—multiple sclerosis	2.57e-05	0.000454	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GPC5—multiple sclerosis	2.55e-05	0.000451	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PTGER4—multiple sclerosis	2.54e-05	0.00045	CbGpPWpGaD
Sildenafil—ABCC5—Disease—APOE—multiple sclerosis	2.53e-05	0.000448	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TYK2—multiple sclerosis	2.5e-05	0.000443	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PGR—multiple sclerosis	2.5e-05	0.000443	CbGpPWpGaD
Sildenafil—PDE6G—Disease—STAT3—multiple sclerosis	2.5e-05	0.000443	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.46e-05	0.000435	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CXCR3—multiple sclerosis	2.45e-05	0.000435	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—IL6—multiple sclerosis	2.43e-05	0.000431	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CD28—multiple sclerosis	2.43e-05	0.00043	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCR2—multiple sclerosis	2.39e-05	0.000423	CbGpPWpGaD
Sildenafil—PDE6G—Disease—MYC—multiple sclerosis	2.33e-05	0.000412	CbGpPWpGaD
Sildenafil—PDE6G—Disease—TGFB1—multiple sclerosis	2.32e-05	0.000411	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—IL2—multiple sclerosis	2.3e-05	0.000407	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CD80—multiple sclerosis	2.29e-05	0.000405	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.28e-05	0.000403	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.28e-05	0.000403	CbGpPWpGaD
Sildenafil—PDE6G—Disease—MAPK1—multiple sclerosis	2.28e-05	0.000403	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—POMC—multiple sclerosis	2.24e-05	0.000397	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—RRM1—multiple sclerosis	2.24e-05	0.000396	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—RRM1—multiple sclerosis	2.23e-05	0.000395	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.23e-05	0.000394	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CNR1—multiple sclerosis	2.2e-05	0.00039	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—APOE—multiple sclerosis	2.12e-05	0.000375	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—RRM1—multiple sclerosis	2.11e-05	0.000373	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.09e-05	0.000371	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.09e-05	0.000371	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.08e-05	0.000369	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—IL2—multiple sclerosis	2.08e-05	0.000369	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.08e-05	0.000368	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.08e-05	0.000368	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—POMC—multiple sclerosis	2.04e-05	0.00036	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.03e-05	0.000359	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CCL2—multiple sclerosis	1.99e-05	0.000353	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CXCL10—multiple sclerosis	1.98e-05	0.000351	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MMP9—multiple sclerosis	1.97e-05	0.000349	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SRM—multiple sclerosis	1.94e-05	0.000344	CbGpPWpGaD
Sildenafil—ABCC5—Disease—TYK2—multiple sclerosis	1.93e-05	0.000342	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.92e-05	0.000339	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.9e-05	0.000336	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—POMC—multiple sclerosis	1.82e-05	0.000322	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—TYK2—multiple sclerosis	1.81e-05	0.00032	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.8e-05	0.000319	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TGFB1—multiple sclerosis	1.79e-05	0.000318	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.77e-05	0.000314	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—MAPK1—multiple sclerosis	1.76e-05	0.000311	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—STAT3—multiple sclerosis	1.75e-05	0.00031	CbGpPWpGaD
Sildenafil—PDE6G—Disease—IL6—multiple sclerosis	1.75e-05	0.000309	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CD4—multiple sclerosis	1.75e-05	0.000309	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CD86—multiple sclerosis	1.74e-05	0.000307	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.73e-05	0.000306	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCL5—multiple sclerosis	1.71e-05	0.000302	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—ALB—multiple sclerosis	1.66e-05	0.000294	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—IL2—multiple sclerosis	1.66e-05	0.000293	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.64e-05	0.00029	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MYC—multiple sclerosis	1.63e-05	0.000288	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TGFB1—multiple sclerosis	1.62e-05	0.000288	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MAPK1—multiple sclerosis	1.59e-05	0.000282	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.59e-05	0.000281	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SPP1—multiple sclerosis	1.58e-05	0.00028	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.57e-05	0.000279	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCR5—multiple sclerosis	1.54e-05	0.000272	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL2RA—multiple sclerosis	1.52e-05	0.000268	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—IL2—multiple sclerosis	1.51e-05	0.000266	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.41e-05	0.000249	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—APOE—multiple sclerosis	1.4e-05	0.000248	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.37e-05	0.000242	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.37e-05	0.000242	CbGpPWpGaD
Sildenafil—ABCC5—Disease—STAT3—multiple sclerosis	1.35e-05	0.000239	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.34e-05	0.000237	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.28e-05	0.000227	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.28e-05	0.000227	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.28e-05	0.000227	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CD80—multiple sclerosis	1.27e-05	0.000224	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MYC—multiple sclerosis	1.26e-05	0.000222	CbGpPWpGaD
Sildenafil—ABCC5—Disease—TGFB1—multiple sclerosis	1.25e-05	0.000222	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.25e-05	0.000222	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MAPK1—multiple sclerosis	1.23e-05	0.000217	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—IL6—multiple sclerosis	1.22e-05	0.000217	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.22e-05	0.000216	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—BCHE—multiple sclerosis	1.21e-05	0.000214	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—POMC—multiple sclerosis	1.2e-05	0.000213	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCL2—multiple sclerosis	1.18e-05	0.000208	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.15e-05	0.000204	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.15e-05	0.000204	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TYK2—multiple sclerosis	1.07e-05	0.000189	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—APOE—multiple sclerosis	1.07e-05	0.000189	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.05e-05	0.000186	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.05e-05	0.000186	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.04e-05	0.000184	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—BCHE—multiple sclerosis	9.91e-06	0.000175	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.56e-06	0.000169	CbGpPWpGaD
Sildenafil—ABCC5—Disease—IL6—multiple sclerosis	9.44e-06	0.000167	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—POMC—multiple sclerosis	9.17e-06	0.000162	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—BCHE—multiple sclerosis	9.12e-06	0.000161	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—BCHE—multiple sclerosis	9.04e-06	0.00016	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL2—multiple sclerosis	8.89e-06	0.000157	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—IL6—multiple sclerosis	8.85e-06	0.000157	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MMP9—multiple sclerosis	8.42e-06	0.000149	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ALB—multiple sclerosis	8.36e-06	0.000148	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—APOE—multiple sclerosis	7.73e-06	0.000137	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—APOE—multiple sclerosis	7.71e-06	0.000137	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—STAT3—multiple sclerosis	7.48e-06	0.000132	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—APOE—multiple sclerosis	7.29e-06	0.000129	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MYC—multiple sclerosis	6.95e-06	0.000123	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TGFB1—multiple sclerosis	6.94e-06	0.000123	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK1—multiple sclerosis	6.8e-06	0.00012	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—POMC—multiple sclerosis	6.64e-06	0.000118	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—POMC—multiple sclerosis	6.63e-06	0.000117	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—POMC—multiple sclerosis	6.26e-06	0.000111	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ALB—multiple sclerosis	6.05e-06	0.000107	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ALB—multiple sclerosis	6.04e-06	0.000107	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—APOE—multiple sclerosis	5.96e-06	0.000106	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.96e-06	0.000106	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ALB—multiple sclerosis	5.71e-06	0.000101	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—APOE—multiple sclerosis	5.49e-06	9.71e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—APOE—multiple sclerosis	5.44e-06	9.63e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL6—multiple sclerosis	5.23e-06	9.25e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—POMC—multiple sclerosis	5.12e-06	9.07e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—POMC—multiple sclerosis	4.71e-06	8.34e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—POMC—multiple sclerosis	4.67e-06	8.27e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ALB—multiple sclerosis	4.67e-06	8.27e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ALB—multiple sclerosis	4.3e-06	7.6e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALB—multiple sclerosis	4.26e-06	7.54e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—APOE—multiple sclerosis	3.59e-06	6.35e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—POMC—multiple sclerosis	3.08e-06	5.45e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALB—multiple sclerosis	2.81e-06	4.97e-05	CbGpPWpGaD
